U. S. Sørensen, E. Pombo-Villar / Tetrahedron 61 (2005) 2697–2703
2701
using silica gel 60 (0.040–0.063 mm) or prepacked silica gel
colums (50 or 70 g). Compounds were visualized on TLC
using UV light and KMnO spraying reagent. Proton and
(2.5 min oven setting 600 W, internal temperature 120 8C,
2-bromo-6-methylpyridine (2.9 mmol, 0.50 g), 1-phenyl-2-
trimethylsilylacetylene (8.9 mmol, 1.50 g), palladium
4
carbon NMR spectra were recorded on a 400 MHz
instrument at 400 and 100 MHz, respectively. Mass
spectrometry analyses were obtained using an LC/MSD
instrument.
acetate (0.14 mmol, 32.0 mg), Bu NCl (2.9 mmol,
4
810 mg), and sodium acetate (11.6 mmol, 951 mg) in dry
DMF (50 ml)). Isolated as the 1,5-naphthalenedisulfonate
salt (crystallized from MeOH—EtOH-Et O), 380 mg
2
(
47%); mp 296–297 8C. Spectra from corresponding free
1 42 1
3.1.1. General procedure for the synthesis of 2-(phenyl-
ethynyl)arenes. Synthesis of 3-(phenylethynyl)pyridine
base: H NMR in correspondence with literature; H NMR
(CDCl ) d 2.57 (s, 3H), 7.05–7.10 (m, 1H), 7.31–7.36 (m,
4H), 7.51–7.62 (m, 3H); C NMR (CDCl
89.0, 122.4, 122.6, 124.4, 128.3, 128.5, 128.8, 132.0, 136.4,
3
1
3
(
(
(
2). Method A (microwave heating). 3-Iodopyridine
2.50 mmol, 512 mg), 1-phenyl-2-trimethylsilylacetylene
5.00 mmol, 872 mg), palladium acetate (0.125 mmol,
) d 24.7, 88.9,
3
C
C
142.7, 158.9. MS (ES ) m/z 194 ([MC1] , 100). Anal.
Calcd for C38 $0.5 H O: C, 66.75; H, 4.57; N,
2
8.1 mg), Bu NCl (2.50 mmol, 695 mg), and sodium
4
H
30
N
2
O
6
S
2
2
acetate (10.0 mmol, 820 mg) in dry DMF (50 ml) were
heated under argon in the Ethos 1600 microwave oven for
4.10; O, 15.20; S, 9.38. Found: C, 66.55; H, 4.53; N, 4.08;
O, 15.23; S, 9.32.
1
4
1
5 minutes regulating the power (initially 450 W thereafter
0–50 W) in order to keep the temperature constant at
00 8C. After cooling to room temperature, the reaction
3.1.6. 2-phenyl-furo[3,2-b]pyridine (5). Method A
(2-bromo-3-hydroxypyridine (5.75 mmol, 1.00 g), 1-phenyl-
2-trimethylsilylacetylene (11.5 mmol, 1.98 g), palladium
mixture was added saturated aqueous NaHCO3 and
extracted three times with EtOAc. The combined organic
phases were dried (MgSO ), filtered, and evaporated to
acetate (0.28 mmol, 64.0 mg), Bu NCl (5.75 mmol, 1.6 g),
4
and sodium acetate (23.0 mmol, 1.9 g) in dry DMF (50 ml).
Reaction temperature 140 8C, 15 min). Solid, 376 mg
4
dryness and the residue purified by CC (0–10% EtOAc in
hexane) to give 2 as a solid in 75% yield (335 mg); mp 47.8–
3
4
1
(33%), mp 91–93 8C (lit. mp 88–89 8C). H NMR in
34,43 1
3
9
9.0 8C (lit. mp 50–51 8C). H NMR in correspondence
1
4
with literature;
correspondence with literature;
7.49 (m, 5H), 7.72–7.92 (m, 3H), 8.50–8.53 (m, 1H);
NMR (CDCl ) d 102.2, 118.0, 118.9, 125.4, 129.0, 129.7,
H NMR (CDCl ) 7.05–
3
3
9 1
13
H NMR (CDCl ) d 7.20–7.25 (m, 1H),
3
C
7
8
8
1
.30–7.36 (m, 3H), 7.51–7.56 (m, 2H), 7.73–7.79 (m, 1H),
3
1
.50–8.55 (m, 1H), 8.75–8.79 (m, 1H); C NMR (CDCl ) d
3
C
C
129.8, 146.2, 148.1, 149.2, 159.8. MS (EI ) m/z 195 (M ,
100). Anal. Calcd for C H NO: C, 79.98; H, 4.65; N, 7.17;
O, 8.20. Found: C, 79.93; H, 4.82; N, 7.16; O, 8.10.
3
6.0, 92.7, 120.4, 122.5, 123.0, 128.4, 128.8, 131.7, 138.4,
48.5, 152.2. MS (ES ) m/z 180 ([MC1] , 100). HRMS:
1
3 9
C
C
Calcd for C H N 180.0813, found 180.0816.
13 10
3.1.7. 3-(Phenylethynyl)quinoline (6). Method A (using in
addition 10 mol % tri(o-tolyl)phosphine). Solid, 316 mg
3
.1.2. Method B (conventional heating). These experi-
1
(55%), mp 67–70 8C. H NMR (CDCl ) d 7.20–7.71 (m,
ments (Table 1) were carried out exactly identical to the
above described (method A), except that the reaction
mixture was put in a preheated (100 8C) oil bath for
3
1
8H), 8.05–8.10 (m, 1H), 8.20 (s, 1H), 8.95 (s, 1H). C NMR
3
(CDCl ) d 86.6, 92.6, 117.4, 122.6, 127.1, 127.2, 127.5,
3
15 min, cooled to room temperature, and worked up as
described for method A.
128.4, 128.8, 129.3, 130.0, 131.7, 138.2, 146.7, 152.0. MS
(ES ) m/z 230 ([MC1] , 100). HRMS: Calcd for C H N
C
C
1
7 12
230.0970, found 230.0970.
3.1.3. Method C (Synthesis of 2 using tetrabutylammo-
nium fluoride (TBAF) in THF). 3-Iodopyridine
3.1.8. Methyl 4-(phenylethynyl)benzoate (7). Method A.
Oil, 40 mg (7%). H NMR in correspondence with
1
(
(
2.87 mmol, 588 mg), 1-phenyl-2-trimethylsilylacetylene
4.30 mmol, 750 mg), and palladium acetate (0.14 mmol,
4
4 1
literature;
(m, 7H), 7.98–8.02 (m, 2H). MS (EI ) m/z 236 (M , 100).
H NMR (CDCl ) d 3.92 (s, 3H), 7.20–7.60
3
C
C
32.2 mg) in dry THF (3 ml) was dropwise added in a 1 M
solution of TBAF in THF (4.30 mmol) and stirred under
argon 3 h at 65 8C. After cooling to rt, the reaction mixture
was added saturated aqueous NaHCO and extracted three
3.1.9. Methyl 3-(phenylethynyl)benzoate (8). Method A
(using in addition 10 mol % tri(o-tolyl)phosphine). Solid,
3
4
5
1
times with EtOAc. The combined organic phases were dried
(
498 mg (84%), mp 77.0–78.2 8C (lit. mp 77–79 8C). H
46 1
MgSO ), filtered, and evaporated to dryness. Compound 2
4
NMR in correspondence with literature; H NMR (CDCl3)
3.93 (s, 3H), 7.34–7.46 (m, 4H), 7.52–7.57 (m, 2H), 7.68–
was isolated as a dark solid in 82% yield (423 mg) by flash
chromatography (0–10% EtOAc in hexane). Compound
characterization ( H NMR and MS) showed that the isolated
1
3
7.72 (m, 1H), 7.97–8.02 (m, 1H), 8.19–8.23 (m, 1H).
NMR (CDCl ) d 52.3, 88.3, 90.3, 122.9, 123.8, 128.4, 128.5,
C
1
3
C
128.6, 129.2, 130.5, 131.7, 132.8, 135.7, 166.5. MS (EI )
product was identical to 2 as described above for method A.
C
m/z 236 (M , 100).
3
.1.4. 2-(Phenylethynyl)pyridine (3). Method A. Oil,
73 mg (39%). H and C NMR in correspondence with
1
13
1
literature;
3.1.10. Methyl 2-(phenylethynyl)benzoate (9). Method A
(from methyl 2-iodobenzoate, using in addition 10 mol %
4
0,41 1
H NMR (CDCl ) d 7.18–7.22 (m, 1H), 7.32–
3
1
tri(o-tolyl)phosphine). Oil, 505 mg (85%). H NMR in
7
8
1
.36 (m, 3H), 7.48–7.52 (m, 1H), 7.57–7.65 (m, 3H), 8.58–
.62 (m, 1H); C NMR (CDCl ) d 88.6, 89.2, 122.2, 122.7,
1
3
47,48 1
3
correspondence with literature;
(s, 3H), 7.31–7.65 (m, 8H), 7.92–7.98 (m, 1H). C NMR
H NMR (CDCl ) 3.95
3
C
27.1, 128.4, 129.0, 132.0, 136.2, 143.4, 150.0. MS (ES )
13
C
m/z 180 ([MC1] , 100).
(CDCl ) d 52.2, 88.2, 94.3, 123.3, 123.7, 127.9, 128.4,
3
C
28.5, 130.5, 131.3, 131.7, 131.9, 134.0, 166.7. MS (ES )
1
m/z 259 ([MCNa] , 100).
C
3
.1.5. 2-Methyl-6-(phenylethynyl)pyridine (4). Method A